uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology.
Show others and affiliations
2009 (English)In: American Journal of Hematology, ISSN 0361-8609, E-ISSN 1096-8652, Vol. 84, no 12, 803-808 p.Article in journal (Refereed) Published
Abstract [en]

Follicular lymphoma (FL) frequently transforms into the more aggressive diffuse large B cell lymphoma (DLBCL-tr), but no protein biomarkers have been identified for predictive or early diagnosis. Gene expression analyses have identified genes changing on transformation but have failed to be reproducible in different studies, reflecting the heterogeneity within the tumor tissue and between tumor samples. Gene expression analyses on Affymetrix Human Genome U133 Plus 2.0 arrays were performed, using flow cytometry sorted tumor cells derived from FL and transformed DLBCL. To identify molecular targets associated with the transformation, subsequent immunohistochemistry (IHC) analyses of the corresponding proteins were performed. Using highly purified cells, this study identified 163 genes, which were significantly deregulated during the transformation in a majority of cases. Among the upregulated transcripts, 13 genes were selected for validation using IHC, based on the availability of commercial antibodies, and galectin-3 and NEK2 proteins specifically identify DLBCL-tr, when compared with FL. We demonstrate that by purifying tumor cells through cell sorting, thereby reducing the heterogeneity due to infiltrating cells, it was possible to identify distinct differences between tumor entities rather than variations due to cellular composition. Galectin-3 and NEK2 both identified a subgroup of DLBCL-tr, and the function of these protein markers also suggests a biological role in the transformation process.

Place, publisher, year, edition, pages
2009. Vol. 84, no 12, 803-808 p.
Keyword [en]
MDM2 SNP309, Chronic lymphocytic leukemia, Binet stage, IGHV mutational status, Genomic aberrations, Prognostic markers
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-121103DOI: 10.1002/ajh.21549ISI: 000272481500008PubMedID: 19844990OAI: oai:DiVA.org:uu-121103DiVA: diva2:304548
Available from: 2010-03-18 Created: 2010-03-18 Last updated: 2010-06-23Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Sundström, ChristerRosenquist, Richard
By organisation
Department of Oncology, Radiology and Clinical ImmunologyDepartment of Genetics and Pathology
In the same journal
American Journal of Hematology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 271 hits
ReferencesLink to record
Permanent link

Direct link